Cell death pathways in photodynamic therapy of cancer

Pawel Mroz, Anastasia Yaroslavsky, Gitika B. Kharkwal, Michael R. Hamblin

Research output: Contribution to journalReview articlepeer-review

516 Scopus citations


Photodynamic therapy (PDT) is an emerging cancer therapy that uses the combination of non-toxic dyes or photosensitizers (PS) and harmless visible light to produce reactive oxygen species and destroy tumors. The PS can be localized in various organelles such as mitochondria, lysosomes, endoplasmic reticulum, Golgi apparatus and plasma membranes and this sub-cellular location governs much of the signaling that occurs after PDT. There is an acute stress response that leads to changes in calcium and lipid metabolism and causes the production of cytokines and stress response mediators. Enzymes (particularly protein kinases) are activated and transcription factors are expressed. Many of the cellular responses center on mitochondria and frequently lead to induction of apoptosis by the mitochondrial pathway involving caspase activation and release of cytochrome c. Certain specific proteins (such as Bcl-2) are damaged by PDT-induced oxidation thereby increasing apoptosis, and a build-up of oxidized proteins leads to an ER-stress response that may be increased by proteasome inhibition. Autophagy plays a role in either inhibiting or enhancing cell death after PDT.

Original languageEnglish (US)
Pages (from-to)2516-2539
Number of pages24
Issue number2
StatePublished - Jun 2011


  • Apoptosis
  • Autophagy
  • Cancer
  • Cell death
  • Necrosis
  • Photodynamic therapy


Dive into the research topics of 'Cell death pathways in photodynamic therapy of cancer'. Together they form a unique fingerprint.

Cite this